Liberum Capital reiterated their buy rating on shares of Medicx Fund (LON:MXF) in a research report report published on Wednesday morning.

Separately, Peel Hunt cut Medicx Fund to a reduce rating and dropped their price objective for the stock from GBX 78 ($1.02) to GBX 72 ($0.94) in a research note on Tuesday, May 22nd.

Shares of Medicx Fund stock opened at GBX 0.77 ($0.01) on Wednesday. Medicx Fund has a 12-month low of GBX 76.75 ($1.00) and a 12-month high of GBX 92.50 ($1.20).

The firm also recently announced a dividend, which will be paid on Friday, September 28th. Investors of record on Thursday, August 16th will be issued a dividend of GBX 1.51 ($0.02) per share. This represents a dividend yield of 1.88%. The ex-dividend date of this dividend is Thursday, August 16th.

Medicx Fund Company Profile

MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 154 properties.

Featured Story: Tariff

Receive News & Ratings for Medicx Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicx Fund and related companies with MarketBeat.com's FREE daily email newsletter.